Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 220

1.

Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.

Bernuzzi F, Marabita F, Lleo A, Carbone M, Mirolo M, Marzioni M, Alpini G, Alvaro D, Muri Boberg K, Locati M, Torzilli G, Rimassa L, Piscaglia F, He XS, Bowlus CL, Yang GX, Eric Gershwin M, Invernizzi P.

Clin Exp Immunol. 2016 Feb 10. doi: 10.1111/cei.12776. [Epub ahead of print]

PMID:
26864161
2.

Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection.

Varchetta S, Mele D, Lombardi A, Oliviero B, Mantovani S, Tinelli C, Spreafico M, Prati D, Ludovisi S, Ferraioli G, Filice C, Aghemo A, Lampertico P, Facchetti F, Bernuzzi F, Invernizzi P, Mondelli MU.

Gut. 2015 Dec 16. pii: gutjnl-2015-310327. doi: 10.1136/gutjnl-2015-310327. [Epub ahead of print]

PMID:
26674359
3.

Geoepidemiology, Genetic and Environmental Risk Factors for PBC.

Zhang H, Carbone M, Lleo A, Invernizzi P.

Dig Dis. 2015;33 Suppl 2:94-101. doi: 10.1159/000440754. Epub 2015 Dec 7.

PMID:
26641264
4.

Making Sense of Autoantibodies in Cholestatic Liver Diseases.

Marzorati S, Invernizzi P, Lleo A.

Clin Liver Dis. 2016 Feb;20(1):33-46. doi: 10.1016/j.cld.2015.08.003. Epub 2015 Oct 9. Review.

PMID:
26593289
5.

An fMRI investigation of motor control in Gilles de la Tourette Syndrome during imagined and executed movements.

Zapparoli L, Porta M, Gandola M, Invernizzi P, Colajanni V, Servello D, Zerbi A, Banfi G, Paulesu E.

Eur J Neurosci. 2015 Nov 13. doi: 10.1111/ejn.13130. [Epub ahead of print]

PMID:
26566185
6.

Postmarketing Safety Study Tool: A Web Based, Dynamic, and Interoperable System for Postmarketing Drug Surveillance Studies.

Sinaci AA, Laleci Erturkmen GB, Gonul S, Yuksel M, Invernizzi P, Thakrar B, Pacaci A, Cinar HA, Cicekli NK.

Biomed Res Int. 2015;2015:976272. doi: 10.1155/2015/976272. Epub 2015 Oct 12.

7.

Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15years.

Selmi C, Ceribelli A, Generali E, Scirè CA, Alborghetti F, Colloredo G, Porrati L, Achenza MI, De Santis M, Cavaciocchi F, Massarotti M, Isailovic N, Paleari V, Invernizzi P, Matthias T, Zucchi A, Meroni PL.

Autoimmun Rev. 2016 Feb;15(2):162-6. doi: 10.1016/j.autrev.2015.10.007. Epub 2015 Oct 30. Review.

PMID:
26524640
8.

INTERPRETATION AND PERCEPTION OF TWO DIFFERENT KUMITE FIGHTING INTENSITIES THROUGH AN INTEGRATED APPROACH TRAINING IN INTERNATIONAL LEVEL KARATEKAS: AN EXPLORATORY STUDY.

Invernizzi PL, Longo S, Bizzi M, Benedini S, Merati G, Bosio A.

Percept Mot Skills. 2015 Oct;121(2):333-49. doi: 10.2466/30.06.PMS.121c19x4. Epub 2015 Oct 7.

PMID:
26445151
9.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Clin Res Hepatol Gastroenterol. 2015 Oct;39(5):e57-9. doi: 10.1016/j.clinre.2015.08.001. No abstract available.

PMID:
26433440
10.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Dig Liver Dis. 2015 Nov;47(11):924-6. doi: 10.1016/j.dld.2015.08.007. Epub 2015 Sep 26. No abstract available.

11.

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Am J Gastroenterol. 2015 Nov;110(11):1536-8. doi: 10.1038/ajg.2015.312. Epub 2015 Sep 29. No abstract available.

12.

Elevated circulating CD14lowCD16+ monocyte subset in primary biliary cirrhosis correlates with liver injury and promotes Th1 polarization.

Peng A, Ke P, Zhao R, Lu X, Zhang C, Huang X, Tian G, Huang J, Wang J, Invernizzi P, Chen Q, Zhuang J.

Clin Exp Med. 2015 Sep 24. [Epub ahead of print]

PMID:
26403460
13.

International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.

Cordell HJ, Han Y, Mells GF, Li Y, Hirschfield GM, Greene CS, Xie G, Juran BD, Zhu D, Qian DC, Floyd JA, Morley KI, Prati D, Lleo A, Cusi D; Canadian-US PBC Consortium; Italian PBC Genetics Study Group; UK-PBC Consortium, Gershwin ME, Anderson CA, Lazaridis KN, Invernizzi P, Seldin MF, Sandford RN, Amos CI, Siminovitch KA.

Nat Commun. 2015 Sep 22;6:8019. doi: 10.1038/ncomms9019.

14.

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Clin Gastroenterol Hepatol. 2015 Nov;13(11):1867-9. doi: 10.1016/j.cgh.2015.08.025. Epub 2015 Sep 18. No abstract available.

PMID:
26386643
15.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

J Hepatol. 2015 Nov;63(5):1285-7. doi: 10.1016/j.jhep.2015.06.031. Epub 2015 Sep 15. No abstract available.

16.

Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Gastroenterology. 2015 Nov;149(6):1627-9. doi: 10.1053/j.gastro.2015.08.031. Epub 2015 Sep 15. No abstract available.

PMID:
26385706
17.

Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Gut. 2015 Nov;64(11):1671-2. doi: 10.1136/gutjnl-2015-310593. Epub 2015 Sep 14. No abstract available.

PMID:
26374822
18.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Hepatology. 2015 Nov;62(5):1620-2. doi: 10.1002/hep.28140. Epub 2015 Sep 15. No abstract available.

PMID:
26372460
19.

Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways.

Hudspeth K, Donadon M, Cimino M, Pontarini E, Tentorio P, Preti M, Hong M, Bertoletti A, Bicciato S, Invernizzi P, Lugli E, Torzilli G, Gershwin ME, Mavilio D.

J Autoimmun. 2016 Jan;66:40-50. doi: 10.1016/j.jaut.2015.08.011. Epub 2015 Aug 30.

PMID:
26330348
20.

Effects of Acute Carnosine and β-Alanine on Isometric Force and Jumping Performance.

Invernizzi PL, Limonta E, Riboli A, Bosio A, Scurati R, Esposito F.

Int J Sports Physiol Perform. 2015 Aug 26. [Epub ahead of print]

PMID:
26308179
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk